Compare Merck Tbk. (MERK) vs Sarana Menara Nusantara Tbk. (TOWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Sarana Menara Nusantara Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Sarana Menara Nusantara Tbk. trades at Rp390 (market cap 22.34T, 68.89M 24h volume). The key difference: Sarana Menara Nusantara Tbk. is far larger — about 13.1× Merck Tbk.'s market cap, and Sarana Menara Nusantara Tbk. is more actively traded (68.89M versus 37.6K). Which is the better fit depends on your goals.
| MERK | TOWR | |
|---|---|---|
Market Cap | 1.7T | 22.34T |
Volume | 37.6K | 68.89M |
Lot | 376 | 688.87K |
Turnover | 144.47M | 26.41B |
Average Price | 3,842.23 | 383.45 |
Value | 144.47M | 26.41B |
Indicative Equilibrium Price | 3,840 | 390 |
Indicative Equilibrium Volume | 7 | 71.22K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Sarana Menara Nusantara Tbk.
PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Read more on TOWR →
